Since the first GLP-1R agonist, exenatide, was approved for the treatment of T2DM in 2005, a variety of GLP-1R agonists such as liraglutide and dulaglutide have been approved
AOD 9604 will only specifically act on fat metabolism, thereby possibly allowing safer and more specific long-term administration and situation unlike in various other weight loss medications, since a variety of other foci are involved
It stays in the body longer, allowing you to take it just once a week
Modeling research published in PMC shows that modest weight loss reduces annual healthcare spending by approximately 15% per person, with effects rising in patients with higher baseline BMI and more comorbidities
What One Month of Semaglutide Can and Cannot Achieve During a single month of semaglutide treatment, most patients experience reduced hunger, smaller meal portions, and initial weight loss of 2-6 pounds depending on starting dose and individual metabolism
But the leap from animal models to human outcomes is large